Usage of gastric antisecretory drugs in palliative care of lung cancer patients

Sumiyo Tanaka, Haruka Kotani, Masayuki Miyazaki, Aya Hirabayashi, Chihiro Murosaki, Kaori Yamashita, Rina Kishi, Akihiro Mouri, Masashi Kondo, Kaoru Shimokata, Yoshinori Hasegawa, Kiyofumi Yamada, Yukihiro Noda

Research output: Contribution to journalArticle

Abstract

Non-steroidal anti-inflammatory drugs (NSAID) and steroids are important drugs that are the most frequently prescribed medications for the relief of cancer pain. However, there is overwhelming evidence that these drugs cause various forms of gastric mucosal injury. Based on clinical experience, gastric antisecretory drugs such as the proton pump inhibitor (PPI) and the histamine-H 2 receptor antagonist (H 2 RA) are widely used to avoid the gastrointestinal problems caused by NSAID and steroids. There are individual differences in how physicians use PPI and H 2 RA. In the present study, we retrospectively examined PPI and H 2 RA usage in the palliative care of 83 lung cancer patients, who were routinely prescribed an NSAID alone (single group) or a combination of an NSAID with a steroid (combination group). We also administered a questionnaire survey to 25 prescribing physicians specializing in respiratory medicine. The proportion of physicians prescribing a PPI prophylactically in the combination group was significantly higher than that of the single group. According to answers in the questionnaire survey, PPI prescribed by physicians in the single group was determined by the performance status and history of gastrointestinal problems in patients. Regardless of such factors, in the combination group, PPI was deliberately prescribed with steroids. Further investigation is needed to examine the clinical effects of PPI in palliative care, so as to establish more appropriate use of both PPI and H 2 RA.

Original languageEnglish
Pages (from-to)251-256
Number of pages6
JournalJapanese Journal of Cancer and Chemotherapy
Volume39
Issue number2
Publication statusPublished - 01-02-2012

Fingerprint

Gastrointestinal Agents
Proton Pump Inhibitors
Palliative Care
Lung Neoplasms
Anti-Inflammatory Agents
Steroids
Pharmaceutical Preparations
Physicians
Pulmonary Medicine
Individuality
Histamine
Stomach
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Tanaka, S., Kotani, H., Miyazaki, M., Hirabayashi, A., Murosaki, C., Yamashita, K., ... Noda, Y. (2012). Usage of gastric antisecretory drugs in palliative care of lung cancer patients. Japanese Journal of Cancer and Chemotherapy, 39(2), 251-256.
Tanaka, Sumiyo ; Kotani, Haruka ; Miyazaki, Masayuki ; Hirabayashi, Aya ; Murosaki, Chihiro ; Yamashita, Kaori ; Kishi, Rina ; Mouri, Akihiro ; Kondo, Masashi ; Shimokata, Kaoru ; Hasegawa, Yoshinori ; Yamada, Kiyofumi ; Noda, Yukihiro. / Usage of gastric antisecretory drugs in palliative care of lung cancer patients. In: Japanese Journal of Cancer and Chemotherapy. 2012 ; Vol. 39, No. 2. pp. 251-256.
@article{100a93718ea14085beaab5fad324f9b1,
title = "Usage of gastric antisecretory drugs in palliative care of lung cancer patients",
abstract = "Non-steroidal anti-inflammatory drugs (NSAID) and steroids are important drugs that are the most frequently prescribed medications for the relief of cancer pain. However, there is overwhelming evidence that these drugs cause various forms of gastric mucosal injury. Based on clinical experience, gastric antisecretory drugs such as the proton pump inhibitor (PPI) and the histamine-H 2 receptor antagonist (H 2 RA) are widely used to avoid the gastrointestinal problems caused by NSAID and steroids. There are individual differences in how physicians use PPI and H 2 RA. In the present study, we retrospectively examined PPI and H 2 RA usage in the palliative care of 83 lung cancer patients, who were routinely prescribed an NSAID alone (single group) or a combination of an NSAID with a steroid (combination group). We also administered a questionnaire survey to 25 prescribing physicians specializing in respiratory medicine. The proportion of physicians prescribing a PPI prophylactically in the combination group was significantly higher than that of the single group. According to answers in the questionnaire survey, PPI prescribed by physicians in the single group was determined by the performance status and history of gastrointestinal problems in patients. Regardless of such factors, in the combination group, PPI was deliberately prescribed with steroids. Further investigation is needed to examine the clinical effects of PPI in palliative care, so as to establish more appropriate use of both PPI and H 2 RA.",
author = "Sumiyo Tanaka and Haruka Kotani and Masayuki Miyazaki and Aya Hirabayashi and Chihiro Murosaki and Kaori Yamashita and Rina Kishi and Akihiro Mouri and Masashi Kondo and Kaoru Shimokata and Yoshinori Hasegawa and Kiyofumi Yamada and Yukihiro Noda",
year = "2012",
month = "2",
day = "1",
language = "English",
volume = "39",
pages = "251--256",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "2",

}

Tanaka, S, Kotani, H, Miyazaki, M, Hirabayashi, A, Murosaki, C, Yamashita, K, Kishi, R, Mouri, A, Kondo, M, Shimokata, K, Hasegawa, Y, Yamada, K & Noda, Y 2012, 'Usage of gastric antisecretory drugs in palliative care of lung cancer patients', Japanese Journal of Cancer and Chemotherapy, vol. 39, no. 2, pp. 251-256.

Usage of gastric antisecretory drugs in palliative care of lung cancer patients. / Tanaka, Sumiyo; Kotani, Haruka; Miyazaki, Masayuki; Hirabayashi, Aya; Murosaki, Chihiro; Yamashita, Kaori; Kishi, Rina; Mouri, Akihiro; Kondo, Masashi; Shimokata, Kaoru; Hasegawa, Yoshinori; Yamada, Kiyofumi; Noda, Yukihiro.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 39, No. 2, 01.02.2012, p. 251-256.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Usage of gastric antisecretory drugs in palliative care of lung cancer patients

AU - Tanaka, Sumiyo

AU - Kotani, Haruka

AU - Miyazaki, Masayuki

AU - Hirabayashi, Aya

AU - Murosaki, Chihiro

AU - Yamashita, Kaori

AU - Kishi, Rina

AU - Mouri, Akihiro

AU - Kondo, Masashi

AU - Shimokata, Kaoru

AU - Hasegawa, Yoshinori

AU - Yamada, Kiyofumi

AU - Noda, Yukihiro

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Non-steroidal anti-inflammatory drugs (NSAID) and steroids are important drugs that are the most frequently prescribed medications for the relief of cancer pain. However, there is overwhelming evidence that these drugs cause various forms of gastric mucosal injury. Based on clinical experience, gastric antisecretory drugs such as the proton pump inhibitor (PPI) and the histamine-H 2 receptor antagonist (H 2 RA) are widely used to avoid the gastrointestinal problems caused by NSAID and steroids. There are individual differences in how physicians use PPI and H 2 RA. In the present study, we retrospectively examined PPI and H 2 RA usage in the palliative care of 83 lung cancer patients, who were routinely prescribed an NSAID alone (single group) or a combination of an NSAID with a steroid (combination group). We also administered a questionnaire survey to 25 prescribing physicians specializing in respiratory medicine. The proportion of physicians prescribing a PPI prophylactically in the combination group was significantly higher than that of the single group. According to answers in the questionnaire survey, PPI prescribed by physicians in the single group was determined by the performance status and history of gastrointestinal problems in patients. Regardless of such factors, in the combination group, PPI was deliberately prescribed with steroids. Further investigation is needed to examine the clinical effects of PPI in palliative care, so as to establish more appropriate use of both PPI and H 2 RA.

AB - Non-steroidal anti-inflammatory drugs (NSAID) and steroids are important drugs that are the most frequently prescribed medications for the relief of cancer pain. However, there is overwhelming evidence that these drugs cause various forms of gastric mucosal injury. Based on clinical experience, gastric antisecretory drugs such as the proton pump inhibitor (PPI) and the histamine-H 2 receptor antagonist (H 2 RA) are widely used to avoid the gastrointestinal problems caused by NSAID and steroids. There are individual differences in how physicians use PPI and H 2 RA. In the present study, we retrospectively examined PPI and H 2 RA usage in the palliative care of 83 lung cancer patients, who were routinely prescribed an NSAID alone (single group) or a combination of an NSAID with a steroid (combination group). We also administered a questionnaire survey to 25 prescribing physicians specializing in respiratory medicine. The proportion of physicians prescribing a PPI prophylactically in the combination group was significantly higher than that of the single group. According to answers in the questionnaire survey, PPI prescribed by physicians in the single group was determined by the performance status and history of gastrointestinal problems in patients. Regardless of such factors, in the combination group, PPI was deliberately prescribed with steroids. Further investigation is needed to examine the clinical effects of PPI in palliative care, so as to establish more appropriate use of both PPI and H 2 RA.

UR - http://www.scopus.com/inward/record.url?scp=84860526591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860526591&partnerID=8YFLogxK

M3 - Article

C2 - 22333637

AN - SCOPUS:84860526591

VL - 39

SP - 251

EP - 256

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 2

ER -

Tanaka S, Kotani H, Miyazaki M, Hirabayashi A, Murosaki C, Yamashita K et al. Usage of gastric antisecretory drugs in palliative care of lung cancer patients. Japanese Journal of Cancer and Chemotherapy. 2012 Feb 1;39(2):251-256.